ARCHIVES

Advisors approve NCI’s revised plan for $104-million proteomics research program.

This article is from The Cancer Letter archive.

Vol. 31 No. 27 | July 8, 2005

Download PDF Visit The Full Archive

Related Articles

Tamoxifen Trial may EB Funded In Part With CCOP Money

March 22, 1991

Consructio Needs Over Next Five Years Total Estimated $696 Million; NCI Share-$132 Million

January 19, 1979

Cancer Support Community Reports on Patient Experiences

October 24, 2014

Drug Approvals: FDA Approves Vectibix in mCRC With KRAS Companion Diagnostic

May 30, 2014

FASEB Urges 6.7 Percent Increase In NIH Budget.

February 1, 2008

NCCN Updates Treatment Guidelines To Include CEF For Early Breast Cancer.

January 26, 2001